Immune ‘hotspots’ could help predict the risk of breast cancer relapse in patients, s
 

Scientists from The Institute of Cancer Research, London has developed a new test through which women at a greater risk of relapsing from breast cancer within 10 years of diagnosis can be identified.

More...